glp-1 and surgery risk Glucose-lowering drugs reduce for obesity-related cancers GLP-1s may reduce cancer risk

As plaques grow, they can become unstable and prone to rupture

Unfortunately, so far, there is no effective treatment for AD

The NNMT Inhibitor May Enhance Muscle Performance Through Increasing NAD+ The studys findings that the NNMT inhibitor, 5-amino-1MQ, improves muscle strength and endurance in aged mice may come from boosting NAD+ levels through increasing cellular levels of its precursor, nicotinamide

Patients should contact their healthcare provider if they experience severe or persistent side effects, signs of hypoglycaemia (particularly if taking insulin or sulfonylureas), symptoms of pancreatitis (severe abdominal pain), or if there is no improvement in blood glucose control after 6 months of treatment at the maximum tolerated dose

Dual roles of PARP-1 promote cancer growth and progression